18 employees
NEXEL is a biotechnology research firm that specializes in the advancement of drugs, biotherapeutics, and iPSC technology.
2012
$16M
from 4 investors over 4 rounds
NEXEL raised $16M on April 16, 2021
Investors: NH Investment & Securities, UTC Investment Co.,Ltd. and Ebest Investment Securities Co Ltd
NEXEL raised undisclosed on March 1, 2017
Investors: TIPS Town